New diabetes clinical trial: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)

Published on: September 18, 2019 at 07:00PM
Condition:   Type 2 Diabetes
Interventions:   Drug: Tirzepatide;   Drug: Insulin Glargine
Sponsor:   Eli Lilly and Company
Not yet recruiting